ELMD
Price
$27.55
Change
+$0.15 (+0.55%)
Updated
Oct 20, 02:14 PM (EDT)
Capitalization
229.23M
21 days until earnings call
Intraday BUY SELL Signals
INBS
Price
$1.51
Change
-$0.02 (-1.31%)
Updated
Oct 20, 11:10 AM (EDT)
Capitalization
5.07M
16 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ELMD vs INBS

ELMD vs INBS Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
ELMD vs. INBS commentary
Oct 20, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELMD is a StrongBuy and INBS is a Hold.

Interact to see
Advertisement
SUMMARIES
A.I.Advisor
a Summary for ELMD with price predictions
Oct 19, 2026

ELMD sees its Stochastic Oscillator ascending out of oversold territory

On October 15, 2026, the Stochastic Oscillator for ELMD moved out of oversold territory and this could be a bullish sign for the stock. Traders may want to buy the stock or buy call options. Tickeron's A.I.dvisor looked at 71 instances where the indicator left the oversold zone. In 56 of the 71 cases the stock moved higher in the following days. This puts the odds of a move higher at over 79%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where ELMD's RSI Indicator exited the oversold zone, 21 of 27 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 78%.

The Moving Average Convergence Divergence (MACD) for ELMD just turned positive on September 17, 2026. Looking at past instances where ELMD's MACD turned positive, the stock continued to rise in 28 of 41 cases over the following month. The odds of a continued upward trend are 68%.

Following a +1.61% 3-day Advance, the price is estimated to grow further. Considering data from situations where ELMD advanced for three days, in 183 of 258 cases, the price rose further within the following month. The odds of a continued upward trend are 71%.

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on ELMD as a result. In 71 of 118 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.

The 50-day moving average for ELMD moved below the 200-day moving average on October 16, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where ELMD declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 66%.

The Aroon Indicator for ELMD entered a downward trend on September 25, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is 42 (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron Profit vs. Risk Rating rating for this company is 57 (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron Price Growth Rating for this company is 58 (best 1 - 100 worst), indicating fairly steady price growth. ELMD’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron PE Growth Rating for this company is 76 (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 100 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (4.247) is normal, around the industry mean (2.908). P/E Ratio (20.000) is within average values for comparable stocks, (2.616). ELMD's Projected Growth (PEG Ratio) (103.010) is very high in comparison to the industry average of (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (3.080) is also within normal values, averaging (40.124).

A.I.Advisor
a Summary for INBS with price predictions
Oct 19, 2026

INBS's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for INBS turned positive on October 16, 2026. Looking at past instances where INBS's MACD turned positive, the stock continued to rise in 35 of 38 cases over the following month. The odds of a continued upward trend are 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where INBS's RSI Oscillator exited the oversold zone, 40 of 46 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 87%.

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 60 of 70 cases where INBS's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 86%.

Following a +6.25% 3-day Advance, the price is estimated to grow further. Considering data from situations where INBS advanced for three days, in 153 of 182 cases, the price rose further within the following month. The odds of a continued upward trend are 84%.

INBS may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The 10-day moving average for INBS crossed bearishly below the 50-day moving average on September 16, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 15 of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where INBS declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.

The Aroon Indicator for INBS entered a downward trend on October 19, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron PE Growth Rating for this company is 20 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of 49 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.921) is normal, around the industry mean (2.908). P/E Ratio (-0.181) is within average values for comparable stocks, (2.616). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (11.052). Dividend Yield (0.000) settles around the average of (0.009) among similar stocks. P/S Ratio (0.688) is also within normal values, averaging (40.124).

The Tickeron Price Growth Rating for this company is 50 (best 1 - 100 worst), indicating steady price growth. INBS’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron SMR rating for this company is 100 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. INBS’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.

FUNDAMENTALS RATINGS
ELMD vs INBS: Fundamental Ratings
ELMD
INBS
OUTLOOK RATING
1..100
8956
VALUATION
overvalued / fair valued / undervalued
1..100
100
Overvalued
49
Fair valued
PROFIT vs RISK RATING
1..100
57100
SMR RATING
1..100
42100
PRICE GROWTH RATING
1..100
5850
P/E GROWTH RATING
1..100
7620
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

INBS's Valuation (49) in the null industry is somewhat better than the same rating for ELMD (100) in the Medical Specialties industry. This means that INBS’s stock grew somewhat faster than ELMD’s over the last 12 months.

ELMD's Profit vs Risk Rating (57) in the Medical Specialties industry is somewhat better than the same rating for INBS (100) in the null industry. This means that ELMD’s stock grew somewhat faster than INBS’s over the last 12 months.

ELMD's SMR Rating (42) in the Medical Specialties industry is somewhat better than the same rating for INBS (100) in the null industry. This means that ELMD’s stock grew somewhat faster than INBS’s over the last 12 months.

INBS's Price Growth Rating (50) in the null industry is in the same range as ELMD (58) in the Medical Specialties industry. This means that INBS’s stock grew similarly to ELMD’s over the last 12 months.

INBS's P/E Growth Rating (20) in the null industry is somewhat better than the same rating for ELMD (76) in the Medical Specialties industry. This means that INBS’s stock grew somewhat faster than ELMD’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ELMDINBS
RSI
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
87%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
86%
Momentum
ODDS (%)
Bearish Trend 1 day ago
60%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
68%
Bullish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
62%
Bullish Trend 1 day ago
83%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
71%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 22 days ago
71%
Bullish Trend 1 day ago
84%
Declines
ODDS (%)
Bearish Trend 1 day ago
66%
Bearish Trend 6 days ago
90%
BollingerBands
ODDS (%)
N/A
Bullish Trend 7 days ago
90%
Aroon
ODDS (%)
Bearish Trend 1 day ago
61%
Bearish Trend 1 day ago
90%
COMPARISON
Comparison
Oct 20, 2026
Stock price -- (ELMD: $27.40 vs. INBS: $1.53)
Brand notoriety: ELMD and INBS are both not notable
Both companies represent the Medical/Nursing Services industry
Current volume relative to the 65-day Moving Average: ELMD: 37% vs. INBS: 11%
Market capitalization -- ELMD: $229.23M vs. INBS: $5.07M
ELMD [@Medical/Nursing Services] is valued at $229.23M. INBS’s [@Medical/Nursing Services] market capitalization is $5.07M. The market cap for tickers in the [@Medical/Nursing Services] industry ranges from $837 to $180.06B. The average market capitalization across the [@Medical/Nursing Services] industry is $5.73B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELMD’s FA Score shows that 0 FA rating(s) are green while INBS’s FA Score has 1 green FA rating(s).

  • ELMD’s FA Score: 0 green, 5 red.
  • INBS’s FA Score: 1 green, 4 red.
According to our system of comparison, INBS is a better buy in the long-term than ELMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELMD’s TA Score shows that 4 TA indicator(s) are bullish while INBS’s TA Score has 5 bullish TA indicator(s).

  • ELMD’s TA Score: 4 bullish, 4 bearish.
  • INBS’s TA Score: 5 bullish, 3 bearish.
According to our system of comparison, INBS is a better buy in the short-term than ELMD.

Price Growth

ELMD (@Medical/Nursing Services) experienced а -2.53% price change this week, while INBS (@Medical/Nursing Services) price change was +0.66% for the same time period.

The average weekly price growth across all stocks in the @Medical/Nursing Services industry was -2.46%. For the same industry, the average monthly price growth was -8.91%, and the average quarterly price growth was -9.61%.

Reported Earning Dates

ELMD is expected to report earnings on Nov 10, 2026.

INBS is expected to report earnings on Nov 05, 2026.

Industries' Descriptions

@Medical/Nursing Services (-2.46% weekly)

The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.

View a ticker or compare two or three
ELMD
Daily Signal:
Gain/Loss:
INBS
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
OEI26.260.13
+0.51%
Optimized Equity Income ETF (OEI)
DWSH5.770.03
+0.45%
AdvisorShares Dorsey Wright Short ETF (DWSH)
GINN79.73N/A
N/A
Innovate Equity ETF (GINN)
SPTS28.71-0.01
-0.03%
State Street SPDR Portfolio Short Term Treasury ETF (SPTS)
AVSF45.69-0.04
-0.09%
Avantis Short-Term Fixed Income ETF (AVSF)

INBS and

Correlation & Price change

A.I.dvisor indicates that over the last year, INBS has been loosely correlated with IVF. These tickers have moved in lockstep 63% of the time. This A.I.-generated data suggests there is some statistical probability that if INBS jumps, then IVF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INBS
1D Price
Change %
INBS100%
+2.00%
IVF - INBS
63%
Loosely correlated
+4.23%
ELMD - INBS
31%
Poorly correlated
-0.07%
NVNO - INBS
27%
Poorly correlated
+4.02%
ITGR - INBS
27%
Poorly correlated
+0.04%
PFSA - INBS
26%
Poorly correlated
-3.32%
More